Latest Revenue Guidance News

Aroa Biosurgery has reported its third consecutive quarter of positive net cash flow, maintaining a strong cash position and reaffirming its FY26 revenue and EBITDA guidance. The company’s Myriad product sales continue to grow, supported by new clinical evidence.

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 amid promising regulatory and market developments.

Mach7 Technologies has updated its FY25 guidance, reporting positive cash flow and a solid financial position, while appointing Teri Thomas as its new CEO to steer the company’s next growth phase.

Mach7 Technologies closes FY25 with solid recurring revenue growth, positive cash flow, and a refreshed leadership team focused on innovation and customer value.

Mastermyne Group forecasts a significant revenue decline for FY25 due to mine suspensions and closures but reports a stronger net cash position and early signs of operational recovery.

Telix Pharmaceuticals reported a robust 63% year-over-year revenue increase to $204 million in Q2 2025, launched its new prostate cancer imaging agent Gozellix in the U.S., and advanced key clinical trials despite an ongoing SEC inquiry.

Amaero Ltd reports solid June quarter revenue and signs a pivotal five-year exclusive supply agreement with Velo3D, underpinning its growth outlook and updated EBITDA guidance for FY2027.

PlaySide Studios has released its unaudited FY25 results, showing revenues just below guidance and an EBITDA loss within expectations amid restructuring. The company remains optimistic about revenue growth and cost savings in FY26, pending the launch of its new title.

Ava Risk Group reports a 5% revenue increase and a positive EBITDA turnaround in FY25, underpinned by its advanced security technologies. The company eyes over $88 million in FY26 sales opportunities despite some project delays.

Ava Risk Group reports a positive EBITDA turnaround for FY2025 despite missing revenue guidance due to delayed key orders. The company highlights strong momentum in telecommunications and aviation sectors with promising technology deployments.

Hansen Technologies has raised its FY25 profitability outlook, driven by operational efficiencies and early powercloud profits, despite a slight revenue timing shift. The company also secured major new contracts across Europe and the US.

Change Financial has surpassed its FY25 revenue targets and is set to report its first positive underlying EBITDA, signaling a pivotal shift for the fintech. The company also projects strong revenue and earnings growth for FY26, underpinned by robust sales momentum and operational efficiencies.